Aqsa Nasir

Aqsa Nasir practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Aqsa Nasir's NPI, 1952703290, was assigned on September 18, 2014. Aqsa Nasir holds Michigan license 4301508322.

Aqsa Nasir's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Aqsa Nasir's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Aqsa Nasir is also affiliated with Fairview Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Aqsa Nasir to 3 more hospitals, 2 clinical labs and 2 medical groups, each named with a free account. Aqsa Nasir's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Aqsa Nasir practices, 7 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Aqsa Nasir's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dmand AI has Aqsa Nasir's licenses on file in 3 states: Michigan, Florida and Minnesota.

CMS data shows 1,718 Medicare services from Aqsa Nasir across 9 procedure codes in 2024, for 678 Medicare patients. Medicare paid $46,281 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 678 Medicare patients who saw Aqsa Nasir in 2024. The largest group is 65 to 74, with 300 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Aqsa Nasir's median patient age at 56, with 56% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Aqsa Nasir for performance year 2024, reported as part of a group. Aqsa Nasir accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Aqsa Nasir from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Astellas Pharma US Inc paid the most, $30.